Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Vycor Medical (VYCO) Enterprise Value (2016 - 2025)

Vycor Medical has reported Enterprise Value over the past 16 years, most recently at -$86982.0 for Q4 2025.

  • Quarterly Enterprise Value rose 17.67% to -$86982.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$86982.0 through Dec 2025, up 17.67% year-over-year, with the annual reading at -$86982.0 for FY2025, 17.67% up from the prior year.
  • Enterprise Value was -$86982.0 for Q4 2025 at Vycor Medical, down from -$64230.0 in the prior quarter.
  • Over five years, Enterprise Value peaked at -$32570.0 in Q3 2022 and troughed at -$157633.0 in Q3 2024.
  • The 5-year median for Enterprise Value is -$66642.5 (2023), against an average of -$73849.3.
  • Year-over-year, Enterprise Value skyrocketed 59.87% in 2022 and then plummeted 128.27% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$90941.0 in 2021, then soared by 59.28% to -$37035.0 in 2022, then tumbled by 54.69% to -$57291.0 in 2023, then tumbled by 84.41% to -$105648.0 in 2024, then rose by 17.67% to -$86982.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Enterprise Value are -$86982.0 (Q4 2025), -$64230.0 (Q3 2025), and -$99700.0 (Q2 2025).